confirmed through a series of clinical trials that upregulating Flt3L expression could enhance immune responses and improve the efficacy of anti‐cervical cancer vaccines, revealing Flt3L's significant role in the pathological process of cervical cancer. The gene discussed is FLT3LG; the disease is cervical carcinoma.